Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Durect Corp (DRRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 355,762
  • Shares Outstanding, K 161,710
  • Annual Sales, $ 49,170 K
  • Annual Income, $ -3,700 K
  • 36-Month Beta 1.15
  • Price/Sales 6.94
  • Price/Cash Flow N/A
  • Price/Book 11.12

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.85 +19.19%
on 05/24/18
2.25 -2.00%
on 06/11/18
+0.26 (+13.66%)
since 05/18/18
3-Month
1.62 +36.11%
on 05/11/18
2.55 -13.53%
on 04/10/18
+0.26 (+13.66%)
since 03/16/18
52-Week
0.75 +194.00%
on 10/20/17
2.55 -13.53%
on 04/10/18
+0.89 (+68.32%)
since 06/16/17

Most Recent Stories

More News
Free Daily Technical Summary Reports on Endo International and Three Other Healthcare Stocks

Stock Research Monitor: ZGNX, DEPO, and DRRX

DRRX : 2.21 (+0.45%)
ENDP : 9.28 (+4.50%)
ZGNX : 46.15 (+2.56%)
DEPO : 7.25 (+1.83%)
New Research Coverage Highlights Durect, Credit Suisse Group, Obsidian Energy, TransCanada, Golden Star Resources, and Loxo Oncology -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Durect Corporation (NASDAQ:DRRX),...

CS : 15.19 (-1.49%)
OBE : 1.14 (+3.64%)
TRP : 42.42 (+2.04%)
DRRX : 2.21 (+0.45%)
GSS : 0.66 (-2.94%)
LOXO : 180.05 (+1.76%)
DURECT Corporation Approaching PDUFA Dates and Analysts Review

NEW YORK, NY / ACCESSWIRE / June 4, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

DRRX : 2.21 (+0.45%)
DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR® (SABER®-Bupivacaine)

DURECT Corporation (Nasdaq: DRRX) today announced it has entered into an amendment (the "Amendment") to the development and commercialization agreement with Sandoz AG, a division of Novartis (NYSE: NVS),...

DRRX : 2.21 (+0.45%)
NVS : 74.02 (-2.34%)
DURECT Corporation Announces First Quarter 2018 Financial Results and Provides Corporate Update

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended March 31, 2018 and provided a corporate update.

DRRX : 2.21 (+0.45%)
DURECT Announces Patient Dosing in Phase 2a Trial of DUR-928 in Alcoholic Hepatitis

DURECT Corporation (Nasdaq: DRRX) today announced it has commenced patient dosing in a Phase 2a clinical trial of DUR-928 in patients with alcoholic hepatitis (AH). DUR-928, the lead investigational product...

DRRX : 2.21 (+0.45%)
DURECT Corporation Invites You to Join its First Quarter 2018 Earnings Conference Call

In conjunction with DURECT Corporation's(Nasdaq: DRRX) first quarter 2018 financial results press release, you are invited to listen to a conference call that will be broadcast live over the internet on...

DRRX : 2.21 (+0.45%)
DURECT Corporation to Host Key Opinion Leader Call on Alcoholic Hepatitis

DURECT Corporation (Nasdaq: DRRX) today announced it will host a key opinion leader (KOL) call on the treatment of alcoholic hepatitis (AH) on Thursday, April 5 at 11:00 a.m. Eastern Time.

DRRX : 2.21 (+0.45%)
Investor Expectations to Drive Momentum within Aon plc, Endeavour Silver, BlackBerry, DURECT, Castle Brands, and Nabors Industries -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aon plc (NYSE:AON), Endeavour...

AON : 139.67 (+0.10%)
BB : 12.24 (-0.57%)
DRRX : 2.21 (+0.45%)
EXK : 3.21 (+0.31%)
ROX : 1.19 (-0.83%)
NBR : 6.41 (-0.31%)
Quotidian Technical Highlights on Selected Drug Makers Stocks -- Depomed, DURECT, Endo, and Ionis Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on DEPO, DRRX, ENDP, and IONS which can be accessed for free by signing up to www.wallstequities.com/registration....

DRRX : 2.21 (+0.45%)
ENDP : 9.28 (+4.50%)
IONS : 42.73 (-8.25%)
DEPO : 7.25 (+1.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade DRRX with:

Business Summary

Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from...

See More

Key Turning Points

2nd Resistance Point 2.27
1st Resistance Point 2.24
Last Price 2.21
1st Support Level 2.13
2nd Support Level 2.05

See More

52-Week High 2.55
Last Price 2.21
Fibonacci 61.8% 1.86
Fibonacci 50% 1.65
Fibonacci 38.2% 1.44
52-Week Low 0.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar